2상모집 중

Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib

연구 개요

The purpose of this study is to better understand how the immune system plays a role in fighting breast cancer and specifically research if the immune system response against breast cancer can be improved with endocrine therapy and cyclin dependent kinase inhibitor therapy in patients with hormone receptor positive breast cancer. This will be studied by collecting tumor tissue and blood samples before and after 2 weeks of study treatment with commonly used endocrine therapy and cyclin dependent kinase inhibitor therapy.

스폰서
협력: 일라이 릴리
적응증
Breast Cancer
중재
Letrozole, Abemaciclib
목표 등록
60
시작일
2021-04-15
완료(예정)
2028-04-15

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.